Myriad, ACLU Clash over Gene IP in NY Court | GenomeWeb

NEW YORK (GenomeWeb News) – After two hours of listening to oral arguments today, a judge in a US District Court in New York said that he will wait to make a decision on whether a case on the legality of the patenting of BRCA1 and BRCA2 genes by Myriad Genetics should be decided, or if it should go to trial or be dismissed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.